Concepedia

Stephen L. DeAngelo

SL

Statistics

Publications

4

Citations

788

H-Index

4

Active since

2016

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

University of Notre Dame

Chinese University of Hong Kong

University of Michigan

Stephen L. DeAngelo is an author at Dana-Farber Cancer Institute specializing in medicinal chemistry, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2016–2025

4

Publications

4

Plasticity in binding confers selectivity in ligand-induced protein degradation

Radosław P. Nowak, Stephen L. DeAngelo, Dennis L. Buckley et al. · Nature Chemical Biology · 2018 · 609 citations · Full text

, , +5

Design and characterization of bivalent BET inhibitors

Minoru Tanaka, Justin M. Roberts, Hyuk‐Soo Seo et al. · Nature Chemical Biology · 2016 · 157 citations · Full text

, , +4

Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer

Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz et al. · 2024 · 11 citations · Full text

Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer

Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz et al. · Cancer Research · 2025 · 11 citations · Full text

1–4 of 4